Aymeric Jung

Part of Yahoo, Inc., eGroups, Inc. operates online portals that enable users to send and receive emails, schedule meetings, share files and photos. The company is based in San Francisco, CA. The company was founded by Scott Hassan.

eWise Group, Inc. provides financial software solutions. It products include money manager, personal data vault, connected insights and resources. The company was founded by Alexander Grinberg in 2000 and is headquartered in Centennial, CO.

Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.

BridgeCo, a networked entertainment pioneer, offers the world’s most comprehensive, cost-effective and highly integrated processor IC and software platforms for connecting Internet media sources, computers and consumer electronics throughout the home. BridgeCo platforms are targeted at the multi-billion dollar global market for stand-alone after-market and embedded audio applications. BridgeCo platforms are the core technologies underlying digital media players (DMPs), audio/video receivers (AVRs), musical instruments and external multi-channel sound cards.

Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland.

PriceMinister SAS provides online marketing and advertising services. Its products include books, videos, electronics, clothes, and cars. The company was founded by Pierre Kosciusko-Morizet, Pierre Krings, Justin Ziegler, and Olivier Mathiot in 2001 and is headquartered in Paris, France.

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

Ethos Services SA (Ethos Services) is the investment management subsidiary of Ethos, Fondation suisse pour un développement durable, created in Geneva, Switzerland in 1997 by two pension funds and backed by institutional investors. Ethos Services provides all investment activities and advising for the Ethos Foundation. They are a leading socially responsible investment firm which provides fund advising and manages discretionary mandates. They provide the opportunity to invest with criteria of sustainable development, actively exercise the voting rights of shareholders and engage in dialogue with companies.

Yelp GmbH is a website and mobile app that connects people with local businesses. It publishes reviews of restaurants, salons, boutiques, dentists, plumbers, and mechanics. It also sells advertisements to local businesses and provides updates on business openings and other events. The company was founded on December 23, 2005 and is headquartered in Hamburg, Germany.

Experteer GmbH provides staff recruitment, job placement and consulting services. The firm services offers to the construction, education, financial, insurance, healthcare, banks, and retail industries. The company was founded by Christian Göttsch in July 2005 and is headquartered in Munich, Germany.

De Pury Pictet Turrettini & Cie SA (PPT) is an independent Swiss asset management firm which was founded in 1996 by David de Pury, Guillaume Pictet and Henri Turrettini to provide asset management, estate advisory and family office services for individual and institutional clients.^ Based in Geneva, the firm has substantial expertise in socially responsible investment, building and optimizing a sustainable portfolio where environmental, social and governance dimensions are integrated into the analysis and management process.

Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA.

Go On Media SAS operates as a digital radio broadcasting service provider in France and Europe. It is a digital radio station that mixes radio and Internet features. The firm offers audio concept and sound identity, production of programs, reports and interviews, Facebook page application with audio player and music programming services. It enables the users to upload their own favorite songs and podcasts as well as to stream their own radio program in high definition quality. The company was founded by Fabrice Gaillard, Emmanuel Jayr and Roberto Ciuleo in 2007 is headquartered in Sevres, France.

Aravis Venture II LP invests in biotechnological start-ups with growth potential.

Solidar'Monde SA specializes in the import and distribution of food products, cosmetics, and handicrafts from fair trade. The company was founded in 1984 and is headquartered in Montreuil, France.

Sustainable Finance Geneva operates as an association that establishes Geneva as the centre for innovation in sustainable finance by engaging individuals and harnessing collective intelligence. The company was founded by Etienne Eichenberger, Jean Yves Daniel Laville, Antoine Mach, Angela de Wolff, Philippe Spicher, Vincent Dufresne, Natacha Guerdat, Olivier Fruchaud, Cédric Lombard, Guillaume Taylor, Elizabeth Umlas, Paul Clements-Hunt, Roland Widmer, Remco Fischer, Antoine Melo and Cheryl Hicks in 2008 and is headquartered in Geneva, Switzerland.

Jamie Oliver Food Foundation is a non-profit organization founded in 2002. The foundation is based in London, UK, and has subsidiaries in the United Kingdom. The British company's mission is to promote healthy eating habits and to tackle obesity. The non-profit company's website provides information about Jamie Oliver's campaigns and how individuals can get involved.

Mytaxi Network Ltd. provides mobile applications for taxi services. The firm offers a smartphone application that acts as a matchmaker between empty cabs and passengers. The company was founded by Russell Hall, Gary Jackson, Terry Runham, Caspar James Tudor Woolley, Jay Bregman and Ronald William Zeghibe in 2010 and is headquartered in London, the United Kingdom.

SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands.

Benchmark Capital Ltd. provides investments advisory services in technology companies. The company is headquartered in Horsham, the United Kingdom.

Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland.

DyCare is a Spanish company that specializes in digital rehabilitation. The company is based in Barcelona, Spain. The company creates ultra-personalized exercises and monitor patients in a simple and effective way. The company's technology allows patients to perform therapeutic exercises using only their mobile phone or tablet camera, assisted by artificial intelligence. The company was founded by Silvia Raga and Ricardo Jauregui, who have been the CEOs since incorporation.